Clinical Trials Directory

Trials / Sponsors / Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc.

Industry · 12 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingAimmune Longitudinal Collaboration Study
Stool Spore Colony Forming Units, Microbiome Composition, Dietary Fiber
N/A2025-10-01
TerminatedOral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
Hen Egg Allergy
Phase 22019-08-20
CompletedPeanut Oral Immunotherapy Study of Early Intervention for Desensitization
Peanut Allergy
Phase 32018-12-27
TerminatedReal World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
Peanut Allergy
Phase 32018-10-24
CompletedLonger-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
Peanut Allergy
Phase 32017-11-02
CompletedAR101 Real-World Open-Label Extension Study
Peanut Allergy
Phase 32017-10-18
CompletedARTEMIS Peanut Allergy In Children
Peanut Allergy
Phase 32017-06-12
CompletedReal-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
Peanut Allergy
Phase 32017-05-08
CompletedPALISADE Follow-on Study (ARC004)
Peanut Allergy
Phase 32016-12-29
CompletedPeanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
Peanut Allergy
Phase 32015-12-22
CompletedOral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On S
Peanut Allergy
Phase 22014-08-27
CompletedOral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
Peanut Allergy
Phase 22014-02-06